SEARCH

SEARCH BY CITATION

References

  • AHERN, G.P. & PREMKUMAR, L.S. (2002). Voltage-dependent priming of rat vanilloid receptor: effects of agonist and protein kinase C activation. J. Physiol.-London, 545, 441451.
  • AHLUWALIA, J., URBAN, L., BEVAN, S., CAPOGNA, M. & NAGY, I. (2002). Cannabinoid 1 receptors are expressed by nerve growth factor- and glial cell-derived neurotrophic factor-responsive primary sensory neurones. Neuroscience, 110, 747753.
  • AHLUWALIA, J., URBAN, L., CAPOGNA, M., BEVAN, S. & NAGY, I. (2000). Cannabinoid 1 receptors are expressed in nociceptive primary sensory neurons. Neuroscience, 100, 685688.
  • AHLUWALIA, J., YAQOOB, M., URBAN, L., BEVAN, S. & NAGY, I. (2003). Activation of capsaicin-sensitive primary sensory neurones induces anandamide production and release. J. Neurochem., 84, 585591.
  • AL-HAYANI, A., WEASE, K.N., ROSS, R.A., PERTWEE, R.G. & DAVIES, S.N. (2001). The endogenous cannabinoid anandamide activates vanilloid receptors in the rat hippocampal slice. Neuropharmacology, 41, 10001005.
  • AMAYA, F., OH-HASHI, K., NARUSE, Y., IIJIMA, N., UEDA, M., SHIMOSATO, G., TOMINAGA, M., TANAKA, Y. & TANAKA, M. (2003). Local inflammation increases vanilloid receptor-1 expression within distinct subgroups of DRG neurones. Brain Res., 963, 190196.
  • ANDERSSON, D.A., ADNER, M., HOGESTATT, E.D. & ZYGMUNT, P.M. (2002). Mechanisms underlying tissue selectivity of anandamide and other vanilloid receptor agonists. Mol. Pharmacol., 62, 705713.
  • BENHAM, C.D., DAVIS, J.B. & RANDALL, A.D. (2002). Vanilloid and TRP channels: a family of lipid-gated cation channels. Neuropharmacology, 42, 873888.
  • BOGER, D.L., SATO, H., LERNER, A.E., HEDRICK, M.P., FECIK, R.A., MIYAUCHI, H., WILKIE, G.D., AUSTIN, B.J., PATRICELLI, M.P. & CRAVATT, B.F. (2000). Exceptionally potent inhibitors of fatty acid amide hydrolase: the enzyme responsible for degradation of endogenous oleamide and anandamide. Proc. Natl. Acad. Sci. U.S.A., 97, 50445049.
  • BORGHINI, I., ANIA-LAHUERTA, A. & REGAZZI, R. (1994). α, βI, βII, δ and ɛ protein kinase C isoforms and compound activity in sciatic nerve of normal and diabetic rats. J. Neurochem., 62, 686696.
  • CAMERON, N.E., COTTER, M.A., JACK, A.M., BASSO, M.D. & HOHMANN, T.C. (1999). Protein kinase C effects on nerve function, perfusion, Na+, K-ATPase activity and glutathione content in diabetic animals. Diabetologia, 42, 11201130.
  • CARR, M.J., KOLLARIK, M., MEEKER, S.N. & UNDEM, B.J. (2002). A role for TRPV1 in bradykinin-induced excitation of vagal airway afferent nerve terminals. J. Pharmacol. Exp. Ther., 304, 12751279.
  • CESARE, P., DEKKER, L.V., SARDINI, A., PARKER, P.J. & MCNAUGHTON, P.A. (1999). Specific involvement of PKC-ɛ in sensitization of the neuronal response to painful heat. Neuron, 23, 617624.
  • CHUANG, H.H., PRESCOTT, E.D., KONG, H.Y., SHIELDS, S., JORDT, S.E., BASBAUM, A.I., CHAO, M.V. & JULIUS, D. (2001). Brady-kinin and nerve growth factor release the capsaicin receptor from PtdIns(4,5)P-2-mediated inhibition. Nature, 411, 957962.
  • CRAIB, S.J., ELLINGTON, H.C., PERTWEE, R.G. & ROSS, R.A. (2001). A possible role of lipoxygenase in the activation of vanilloid receptors by anandamide in the guinea-pig isolated bronchus. Br. J. Pharmacol., 134, 3037.
  • CRAVATT, B.F., DEMAREST, K., PATRICELLI, M.P., BRACEY, M.H., GIANG, D.K., MARTIN, B.R. & LICHTMAN, A.H. (2001). Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. Proc. Natl. Acad. Sci. U.S.A., 98, 93719376.
  • DAVIES, S.N., PERTWEE, R.G. & RIEDEL, G. (2002). Functions of cannabinoid receptors in the hippocampus. Neuropharmacology, 42, 9931007.
  • DE PETROCELLIS, L., BISOGNO, T., MACCARRONE, M., DAVIS, J.B., FINAZZI-AGRO, A. & DI MARZO, V. (2001a). The activity of anandamide at vanilloid VR1 receptors requires facilitated transport across the cell membrane and is limited by intracellular metabolism. J. Biol. Chem., 276, 1285612863.
  • DE PETROCELLIS, L., DAVIS, J.B. & DI MARZO, V. (2001b). Palmitoylethanolamide enhances anandamide stimulation of human vanilloid VR1 receptors. FEBS Lett., 506, 253256.
  • DE PETROCELLIS, L., HARRISON, S., BISOGNO, T., TOGNETTO, M., BRANDI, I., SMITH, G.D., CREMINON, C., DAVIS, J.B., GEPPETTI, P. & DI MARZO, V. (2001c). The vanilloid receptor (VR1)-mediated effects of anandamide are potently enhanced by the cAMP-dependent protein kinase. J. Neurochem., 77, 16601663.
  • DE PETROCELLIS, L., ORLANDO, P. & DI MARZO, V. (1995). Anandamide, an endogenous cannabinomimetic substance, modulates rat brain protein kinase C in vitro. Biochem. Mol. Biol. Int., 36, 11271133.
  • DI MARZO, V. (2002). Foreword-endocannabinoids in the new millennium. Prostaglandins Leukot. Essent. Fatty Acids, 66, 9192.
  • DI MARZO, V., BISOGNO, T. & DE PETROCELLIS, L. (2001). Anandamide: some like it hot. Trends Pharmacol. Sci., 22, 346349.
  • DI MARZO, V., BLUMBERG, P.M. & SZALLASI, A. (2002a). Endovanilloid signaling in pain. Curr. Opin. Neurobiol., 12, 372379.
  • DI MARZO, V., DE PETROCELLIS, L., FEZZA, F., LIGRESTI, A. & BISOGNO, T. (2002b). Anandamide receptors. Prostaglandins Leukot. Essent. Fatty Acids, 66, 377391.
  • DI MARZO, V., FONTANA, A., CADAS, H., SCHINELLI, S., CIMINO, G., SCHWARTZ, J.C. & PIOMELLI, D. (1994). Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature, 372, 686691.
  • EDGEMOND, W.S., HILLARD, C.J., FALCK, J.R., KEARN, C.S. & CAMPBELL, W.B. (1998). Human platelets and polymorphonuclear leukocytes synthesize oxygenated derivatives of arachidonylethanolamide (anandamide): their affinities for cannabinoid receptors and pathways of inactivation. Mol. Pharmacol., 54, 180188.
  • ELLINGTON, H.C., COTTER, M.A., CAMERON, N.E. & ROSS, R.A. (2002). The effect of cannabinoids on capsaicin-evoked calcitonin gene-related peptide (CGRP) release from the isolated paw skin of diabetic and non-diabetic rats. Neuropharmacology, 42, 966975.
  • FARQUHAR-SMITH, W.P., EGERTOVA, M., BRADBURY, E.J., MCMAHON, S.B., RICE, A.S.C. & ELPHICK, M.R. (2000). Cannabinoid CB1 receptor expression in rat spinal cord. Mol. Cell. Neurosci., 15, 510521.
  • GARCIA, D.E., BROWN, S., HILLE, B. & MACKIE, K. (1998). Protein kinase C disrupts cannabinoid actions by phosphorylation of the CB1 cannabinoid receptor. J. Neurosci., 18, 28342841.
  • GERAGHTY, D.P. & MAZZONE, S.B. (2002). Respiratory actions of vanilloid receptor agonists in the nucleus of the solitary tract: comparison of resiniferatoxin with non-pungent agents and anandamide. Br. J. Pharmacol., 137, 919927.
  • GLASER, S., ABUMRAD, N.A., FATADE, F., KACZOCHA, M., STUDHOLME, K.M. & DEUTSCH, D. (2003). Evidence against the presence of an anandamide transporter. Proc. Natl. Acad. Sci. U.S.A., 100, 42694274.
  • GOMEZ DEL PULGAR, T., DE CEBALLOS, M.L., GUZMAN, M. & VELASCO, G. (2002). Cannabinoids protect astrocytes from ceramide-induced apoptosis through the phosphatidylinositol 3-kinase/protein kinase B pathway. J. Biol. Chem., 277, 36527.
  • HÁJOS, N. & FREUND, T.F. (2002a). Pharmacological separation of cannabinoid sensitive receptors on hippocampal excitatory and inhibitory fibers. Neuropharmacolgy, 43, 503510.
  • HÁJOS, N. & FREUND, T.F. (2002b). Distinct cannabinoid sensitive receptors regulate hippocampal excitation and inhibition. Chem. Phys. Lipids, 121, 7382.
  • HARRIS, D., MCCULLOCH, A.I., KENDALL, D.A. & RANDALL, M.D. (2002). Characterization of vasorelaxant responses to anandamide in the rat mesenteric arterial bed. J. Physiol., 539, 893902.
  • HERMANN, H., DE PETROCELLIS, L., BISOGNO, T., SCHIANO MORIELLO, A., LUTZ, B. & DI MARZO, V. (2003). Dual effect of cannabinoid CB1 receptor stimulation on a vanilloid VR1 receptor-mediated response. Cell. Mol. Life Sci., 60, 607616.
  • HO, B.Y., UEZONO, Y., TAKADA, S., TAKASE, I. & IZUMI, F. (1999). Coupling of the expressed cannabinoid CB1 and CB2 receptors to phospholipase C and G-protein-coupled inwardly rectifying K+ channels. Receptors Channels, 6, 363374.
  • HÖGESTÄTT, E.D. & ZYGMUNT, P.M. (2002). Cardiovascular pharmacology of anandamide. Prostaglandins Leukot. Essent. Fatty Acids, 66, 343351.
  • HUANG, S.M., BISOGNO, T., TREVISANI, M., AL-HAYANI, A., DE PETROCELLIS, L., FEZZA, F., TOGNETTO, M., PETROS, T.J., KREY, J.F., CHU, C.J., MILLER, J.D., DAVIES, S.N., GEPPETTI, P., WALKER, J.M. & DI MARZO, V. (2002). An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors. Proc. Natl. Acad. Sci. U.S.A., 99, 84008405.
  • HUDSON, L.J., BEVAN, S., WOTHERSPOON, G., GENTRY, C., FOX, A.M. & WINTER, J. (2001). VR1 protein expression increases in undamaged DRG neurons after partial nerve injury. Eur. J. Neurosci., 12, 21052114.
  • HURST, D.P., LYNCH, D.L., BARNETT-NORRIS, J., HYATT, S.M., SELTZMAN, H.H., ZHONG, M., SONG, Z.H., NIE, J.J., LEWIS, D. & REGGIO, P.H. (2002). N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716A) interaction with LYS 3.28(192) is crucial for its inverse agonism at the cannabinoid CB1 receptor. Mol. Pharmacol., 62, 12741287.
  • HWANG, S.W., HAWOON, C., KWAK, J., LEE, S.-Y., KANG, C.-J., JUNG, J., CHO, S., MIN, K.H., SUH, Y.-G., KIM, G. & OH, U. (2000). Direct activation of capsaicin receptors by products of lipoxygenase: endogenous capsaicin-like substances. Proc. Nat. Acad. Sci. U.S.A., 97, 61556160.
  • HWANG, S.W. & OH, U. (2002). Hot channels in airways: pharmacology of the vanilloid receptor. Curr. Opin. Pharmacol., 2, 235242.
  • IVERSEN, L. & CHAPMAN, V. (2002). Cannabinoids: a real prospect for pain relief Curr. Opin. Pharmacol., 2, 5055.
  • JERMAN, J.C., GRAY, J., BROUGH, S.J., OOI, L., OWEN, D., DAVIS, J.B. & SMART, D. (2002). Comparison of effects of anandamide at recombinant and endogenous rat vanilloid receptors. Br. J. Anesthesia, 89, 882887.
  • JIA, Y.L., MCLEOD, R.L., WANG, X., PARRA, L.E., EGAN, R.W. & HEY, J.A. (2002). Anandamide induces cough in conscious guinea-pigs through VR1 receptors. Br. J. Pharmacol., 137, 831836.
  • JORDT, S.E. & JULIUS, D. (2002). Molecular basis for species specificity to ‘hot’ chili peppers. Cell, 108, 421430.
  • JUNG, J., HWANG, S.W., KWAK, J., LEE, S.Y., KANG, C.J., KIM, W.B., KIM, D. & OH, U. (1999). Capsaicin binds to the intracellular domain of the capsaicin-activated ion channel. J. Neurosci., 19, 529538.
  • KAGAYA, M., LAMB, J., ROBBINS, J., PAGE, C.P. & SPINA, D. (2002). Characterization of the anandamide induced depolarization of guinea-pig isolated vagus nerve. Br. J. Pharmacol., 137, 3948.
  • KAMEI, J., ZUSHIDA, K., MORITA, K., SASAKI, M. & TANAKA, S.I. (2001). Role of vanilloid VR1 receptor in thermal allodynia and hyperalgesia in diabetic mice. Eur. J. Pharmacol., 422, 8386.
  • KHASABOVA, I.A., SIMONE, D.A. & SEYBOLD, V.S. (2002). Cannabinoids attenuate depolarization-dependent Ca2+ influx in intermediate-size primary afferent neurons of adult rats. Neuroscience, 115, 613625.
  • KOYA, D. & KING, G.L. (1998). Protein kinase C activation and the development of diabetic complications. Diabetes, 47, 859866.
  • KOZAK, K.R. & MARNETT, L.J. (2002). Oxidative metabolism of endocannabinoids. Prostaglandins Leukot. Essent. Fatty Acids, 66, 211220.
  • LEVER, I.J. & MALCANGIO, M. (2002). CB1 receptor antagonist SR141716A increases capsaicin-evoked release of substance P from the adult mouse spinal cord. Br. J. Pharmacol., 135, 2124.
  • MACCARRONE, M., BARI, M., LORENZON, T., BISOGNO, T., DI MARZO, V. & FINAZZI-AGRO, A. (2000a). Anandamide uptake by human endothelial cells and its regulation by nitric oxide. J. Biol. Chem., 275, 1348413492.
  • MACCARRONE, M., FIORUCCI, L., ERBA, F., BARI, M., FINAZZIAGRO, A. & ASCOLI, F. (2000b). Human mast cells take up and hydrolyze anandamide under the control of 5-lipoxygenase and do not express cannabinoid receptors. FEBS Lett., 468, 176180.
  • MACCARRONE, M., LORENZON, T., BARI, M., MELINO, G. & FINAZZI-AGRO, A. (2000c). Anandamide induces apoptosis in human cells via vanilloid receptors – evidence for a protective role of cannabinoid receptors. J. Biol. Chem., 275, 3193531938.
  • MACCARRONE, M., SALVATI, S., BARI, M. & FINAZZI-AGRO, A. (2000d). Anandamide and 2-arachidonoylglycerol inhibit fatty acid amide hydrolase by activating the lipoxygenase pathway of the arachidonate cascade. Biophys. Res. Commun., 278, 576583.
  • MANG, C.F., ERBELDING, D. & KILBINGER, H. (2001). Differential effects of anandamide on acetylcholine release in the guinea-pig ileum mediated via vanilloid and non-CB1 cannabinoid receptors. Br. J. Pharmacol., 134, 161167.
  • MARINELLI, S., DI MARZO, V., BERRETTA, N., MATIAS, I., MACCARRONE, M., BERNARDI, G. & MERCURI, N.B. (2003). Presynaptic facilitation of glutamatergic synapses to dopaminergic neurones of the rat substantia nigra by endogenous stimulation of vanilloid receptors. J. Neurosci., 23, 31363144.
  • MARINELLI, S., VAUGHAN, C.W., CHRISTIE, M.J. & CONNOR, M. (2002). Capsaicin activation of glutamatergic synaptic transmission in the rat locus coeruleus in vitro. J. Physiol., 543, 531540.
  • MARSHALL, I.C.B., OWEN, D.E., CRIPPS, T.V., DAVIS, J.B., MCNULTY, S. & SMART, D. (2003). Activation of vanilloid receptor 1 by resiniferatoxin mobilizes calcium from inositol 1,4,5-triphosphate-sensitive stores. Br. J. Pharmacol., 138, 172176.
  • MARTIN, W.J., LIU, H., WANG, H., MALMBERG, A.B. & BASBAUM, A.I. (1999). Inflammation-induced up-regulation of protein kinase Cγ immunoreactivity in rat spinal cord correlates with enhanced nociceptive processing. Neuroscience, 88, 12671274.
  • MCCLEAN, P.G., ASTON, D., SARKAR, D. & AHLUWALIA, A. (2002). Protease-activated receptor-2 activation causes EDHF-like coro-nary vasodilation. Circ. Res., 90, 465472.
  • MCVEY, D.C., SCHMID, P.C., SCHMID, H.H.O. & VIGNA, S.R. (2002). Endocannabinoids induce ileitis in rats via the capsaicin receptor (VR1). J. Pharmacol. Exp. Ther., 304, 713722.
  • MELCK, D., BISOGNO, T., DE PETROCELLIS, L., CHUANG, H.H., JULIUS, D., BIFULCO, M. & DI MARZO, V. (1999). Unsaturated long-chain N-acyl-vanillyl-amides (N-AVAMs): vanilloid receptor ligands that inhibit anandamide-facilitated transport and bind to CB1 cannabinoid receptors. Biochem. Biophys. Res. Commun., 262, 275284.
  • MEZEY, E., TOTH, Z.E., CORTRIGHT, D.N., ARZUBI, M.K., KRAUSE, J.E., ELDE, R., GOU, A., BLUMBERG, P.M. & SZALLASI, A. (2000). Distribution of mRNA for vanilloid subtype 1 (VR1), and VR1-like immunoreactivity in the central nervous system of the rat and human. Proc. Nat. Acad. U.S.A., 97, 36553660.
  • MORISSET, V., AHLUWALIA, J., NAGY, I. & URBAN, L. (2001). Possible mechanisms of cannabinoid-induced antinociception in the spinal cord. Eur. J. Pharmacol., 429, 93100.
  • NAGY, I., AHLUWALIA, J. & URBAN, L. (2002). Dual effect of anandamide on nociceptive primary sensory neurones. Soc. Neurosci. Abstr., 2002, 65.
  • NETZEBAND, J.G., CONROY, S.M., PARSONS, K.L. & GRUOL, D.L. (1999). Cannabinoids enhance NMDA-elicited Ca2+ signals in cerebellar granule neurons in culture. J. Neurosci., 19, 87658777.
  • NUMAZAKI, M., TOMINAGA, T., TOYOOKA, H. & TOMINAGA, M. (2002). Phosphorylation of capsaicin receptor VR1 by protein kinase C and identification of two target serine residues. J. Biol. Chem., 277, 1337513378.
  • OLAH, Z., KARAI, L. & IADAROLA, M.J. (2001). Anandamide activates vanilloid receptor 1 (VR1) at acidic pH in dorsal root ganglia neurons and cells ectopically expressing VR1. J. Biol. Chem., 276, 3116331170.
  • OLAH, Z., KARAI, L. & IADAROLA, M.J. (2002). Protein kinase C alpha is required for vanilloid receptor 1 activation – evidence for multiple signaling pathways. J. Biol. Chem., 277, 3575235759.
  • ORLIAC, M.L., PERONI, R., CELUCH, S.M. & ADLER-GRACHINSKY, E. (2003). Potentiation of anandamide effects in mesenteric beds isolated from endotoxemic rats. J. Pharmacol. Exp. Ther., 304, 179184.
  • PAROLARO, D., MASSI, P., RUBINO, T. & MONTI, E. (2002). Endocannabinoids in the immune system and cancer. Prostaglandins Leukot. Essent. Fatty Acids, 66, 319332.
  • PERTWEE, R.G. (2003). Inverse agonism at cannabinoid receptors. In: Esteve Foundation Symposium X. Inverse Agonism. Amsterdam: Elsevier, (in press).
  • PERTWEE, R.G. & ROSS, R.A. (2002). Cannabinoid receptors and their ligands. Prostaglandins Leukot. Essent. Fatty Acids, 66, 101121.
  • PIOMELLI, D. (2001). The ligand that came from within. Trends Pharmacol. Sci., 22, 1719.
  • PREMKUMAR, L.S. & AHERN, G.P. (2000). Induction of vanilloid receptor channel activity by protein kinase C. Nature, 408, 985990.
  • RALEVIC, V., KENDALL, D.A., JERMAN, J.C., MIDDLEMISS, D.N. & SMART, D. (2001). Cannabinoid activation of recombinant and endogenous vanilloid receptors. Eur. J. Pharmacol., 424, 211219.
  • RALEVIC, V., KENDALL, D.A., RANDALL, M.D. & SMART, D. (2002). Cannabinoid modulation of sensory neurotransmission via cannabinoid and vanilloid receptors: roles in regulation of cardiovascular function. Life Sci., 71, 25772594.
  • RANDALL, M.D., HARRIS, D., KENDALL, D.A. & RALEVIC, V. (2002). Cardiovascular effects of cannabinoids. Pharmacol. Ther., 95, 191202.
  • RICE, A.S.C., FARQUHAR-SMITH, W.P. & NAGY, I. (2002). Endocannabinoids and pain: spinal and peripheral analgesia in inflammation and neuropathy. Prostaglandins Leukot. Essent. Fatty Acids, 66, 243256.
  • RICHARDSON, J.D., KILO, S. & HARGREAVES, K.M. (1998). Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors. Pain, 75, 111119.
  • ROBERTS, L.A., CHRISTIE, M.J. & CONNOR, M. (2002). Anandamide is a partial agonist at native vanilloid receptors in acutely isolated mouse trigeminal sensory neurons. Br. J. Pharmacol., 137, 421428.
  • ROSS, R.A., COUTTS, A.A., MCFARLANE, S., IRVING, A.J., PERTWEE, R.G., MACEWAN, D.J. & SCOTT, R.H. (2001a). Actions of cannabinoid receptor ligands on rat cultured sensory neurones: implications for antinociception. Neuropharmacology, 40, 221232.
  • ROSS, R.A., CRAIB, S.J., STEVENSON, L.A., PERTWEE, R.G., HENDERSON, A., TOOLE, J. & ELLINGTON, H.C. (2002). Pharmacological characterization of the anandamide cyclooxygenase metabolite: prostaglandin E2 ethanolamide. J. Pharmacol. Exp. Ther., 301, 900907.
  • ROSS, R.A., GIBSON, T.M., BROCKIE, H.C., LESLIE, M., PASHMI, G., CRAIB, S.J., DI MARZO, V. & PERTWEE, R.G. (2001b). Structure – activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferens. Br. J. Pharmacol., 132, 631640.
  • SAVIDGE, J., DAVIS, C., SHAH, K., COLLEY, S., PHILLIPS, E., RANASINGHE, S., WINTER, J., KOTSONIS, P., RANG, H. & MCINTYRE, P. (2002). Cloning and functional characterization of the guinea pig vanilloid receptor 1. Neuropharmacology, 43, 450456.
  • SHIN, J., CHO, H., HWANG, S.W., JUNG, J., SHIN, C.Y., LEE, S.-Y., KIM, S.H., LEE, M.G., CHOI, Y.H., KIM, J., HABER, N.A., REICHLING, D.B., KHASAR, S., LEVINE, J.D. & OH, U. (2002). Bradykinin-12-lipoxygenase-VR1 signalling pathway for inflammatory hyperalgesia. Proc. Natl. Acad. Sci. U.S.A., 99, 1015010155.
  • SMART, D., GUNTHORPE, M.J., JERMAN, J.C., NASIR, S., GRAY, J., MUIR, A.I., CHAMBERS, J.K., RANDALL, A.D. & DAVIS, J.B. (2000). The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1). Br. J. Pharmacol., 129, 227230.
  • SMART, D., JERMAN, J.C., GUNTHORPE, M.J., BROUGH, S.J., RANSON, J., CAIRNS, W., HAYES, P.D., RANDALL, A.D. & DAVIS, J.B. (2001). Characterisation using FLIPR of human vanilloid VR1 receptor pharmacology. Eur. J. Pharmacol., 417, 5158.
  • SMART, D., JONSSON, K.O., VANDEVOORDE, S., LAMBERT, D.M. & FOWLER, C.J. (2002). ‘Entourage’ effects of N-acyl ethanolamines at human vanilloid receptors. Comparison of effects upon anandamide-induced vanilloid receptor activation and upon anandamide metabolism. Br. J. Pharmacol., 136, 452458.
  • SPRAGUE, J., HARRISON, C., ROWBOTHAM, D.J., SMART, D. & LAMBERT, D.G. (2001). Temperature-dependent activation of recombinant rat vanilloid VR1 receptors expressed in HEK293 cells by capsaicin and anandamide. Eur. J. Pharmacol., 423, 121125.
  • SPINA, D. & PAGE, C.P. (2002). Asthma – a need for a re-think TIPS, 23, 311315.
  • SZALLASI, A. (2002). Vanilloid (capsaicin) receptors in health and disease. Am. J. Clin. Pathol., 118, 110121.
  • TREVISANI, M., SMART, D., GUNTHORPE, M.J., TOGNETTO, M., BARBIERI, M., CAMPI, B., AMADESI, S., GRAY, J., JERMAN, J.C., BROUGH, S.J., OWEN, D., SMITH, G.D., RANDALL, A.D., HARRISON, S., BIANCHI, A., DAVIS, J.B. & GEPPETTI, P. (2002). Ethanol elicits and potentiates nociceptor responses via the vanilloid receptor-1. Nat. Neurosci., 5, 546551.
  • TOGNETTO, M., AMADESI, S., HARRISON, S., CREMINON, C., TREVISANI, M., CARRERAS, M., MATERA, M., GEPPETTI, P. & BIANCHI, A. (2001). Anandamide excites central terminals of dorsal root ganglion neurons via vanilloid receptor-1 activation. J. Neurosci., 21, 11041109.
  • TUCKER, R.C., KAGAYA, M., PAGE, C.P. & SPINA, D. (2001). The endogenous cannabinoid agonist, anandamide stimulates sensory nerves in guinea-pig airways. Br. J. Pharmacol., 132, 11271135.
  • VAN DER STELT, M., VAN KUIK, J.A., BARI, M., VAN ZADELHOFF, G., LEEFLANG, B.R., VELDINK, G.A., FINAZZI-AGRO, A., VLIEGENTHART, J.F.G. & MACCARRONE, M. (2002). Oxygenated metabolites of anandamide and 2-arachidonoylglycerol: conformational analysis and interaction with cannabinoid receptors, membrane transporter, and fatty acid amide hydrolase. J. Med. Chem., 45, 37093720.
  • VELLANI, V., MAPPLEBECK, S., MORIONDO, A., DAVIS, J.B. & MCNAUGHTON, P.A. (2001). Protein kinase C activation potentiates gating of the vanilloid receptor VR1 by capsaicin, protons, heat and anandamide. J. Physiol., 534, 813825.
  • WALKER, J.M. & HUANG, S.M. (2002). Endocannabinoids in pain modulation. Prostaglandins Leukot. Essent. Fatty Acids, 66, 235242.
  • WARDLE, K.A., RANSON, J. & SANGER, G.J. (1997). Pharmacological characterisation of the vanilloid receptor in the rat dorsal spinal cord. Br. J. Pharmacol., 121, 10121016.
  • WINSTON, J., TOMA, H., SHENOY, M. & PASRICHA, P.J. (2001). Nerve growth factor regulates VR-1 mRNA levels in cultures of adult dorsal root ganglion neurones. Pain, 89, 181186.
  • WINTER, J., FORBES, C.A. & CAMPBELL, E.A. (1988). Nerve growth factor (NGF) regulates adult rat cultured dorsal root ganglion neuron responses to excitotoxin capsaicin. Neuron, 1, 972981.
  • YIANGOU, Y., FACER, P., DYER, N.H., CHAN, C.L., KNOWLES, C., WILLIAMS, N.S. & ANAD, P. (2001). Vanilloid receptor 1 immunoreactivity in inflamed human bowel. Lancet, 357, 13381339.
  • ZYGMUNT, P.M., PETERSSON, J., ANDERSSON, D.A., CHUANG, H., SΦRGÅRD, M., DI MARZO, V., JULIUS, D. & HÖGESTÄTT, E.D. (1999). Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature, 400, 452457.